In our study, both genetic and drug-induced BMI1 regulation decreased RNA expression of BCL-2, a known protein with anti-apoptotic functions [48], suggesting deregulation of both mitosis and cancer-associated survival mechanisms upon BMI1 inhibition. The gene discussed is BMI1; the disease is cancer.